{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:22:15Z","timestamp":1793467335397,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12185-020-03028-z","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T13:03:02Z","timestamp":1605099782000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-2918","authenticated-orcid":false,"given":"Shinya","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidesaku","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"3028_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2310\/6670.2009.00046","volume":"17","author":"IM Nordon","year":"2009","unstructured":"Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM. Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular. 2009;17:253\u201363.","journal-title":"Vascular"},{"key":"3028_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2:20.","journal-title":"J Intensive Care"},{"key":"3028_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MBC.0000000000000902","volume":"31","author":"S Yamada","year":"2020","unstructured":"Yamada S, Okumura H, Morishita E, Asakura H. Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation. Blood Coagul Fibrinolyisis. 2020;31:274\u20138.","journal-title":"Blood Coagul Fibrinolyisis"},{"key":"3028_CR4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archinte.1967.00290230160008","volume":"119","author":"NL Fine","year":"1967","unstructured":"Fine NL, Applebaum J, Elguezabal A, Castleman L. Multiple coagulation defects in association with dissecting aneurysm. Arch Intern Med. 1967;119:522\u20136.","journal-title":"Arch Intern Med"},{"key":"3028_CR5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586\u201392.","journal-title":"N Engl J Med"},{"key":"3028_CR6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archsurg.1983.01390110010002","volume":"118","author":"DF Fisher Jr","year":"1983","unstructured":"Fisher DF Jr, Yawn DH, Crawford ED. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg. 1983;118:1252\u20135.","journal-title":"Arch Surg"},{"key":"3028_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(75)90351-4","volume":"59","author":"JW Tencare","year":"1975","unstructured":"Tencare JW, Timmers H, Becker AE. Coagulopathy in ruptured or dissecting aortic aneurysm. Am J Med. 1975;59:171\u20136.","journal-title":"Am J Med"},{"key":"3028_CR8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0741-5214(87)90278-3","volume":"6","author":"H Mukaiyama","year":"1987","unstructured":"Mukaiyama H, Shinoyama S, Ikezawa T, Kamiya T, Hamaguchi M, Saito H. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment. J Vasc Surg. 1987;6:600\u20134.","journal-title":"J Vasc Surg"},{"key":"3028_CR9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02138148","volume":"27","author":"HR Baumgartner","year":"1971","unstructured":"Baumgartner HR, Stemerman MB, Spaet TH. Adhesion of blood platelets to subendothelial surface: distinct from adhesion to collagen. Experienta. 1971;27:283.","journal-title":"Experienta"},{"key":"3028_CR10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jcp.19.2.154","volume":"19","author":"CRM Prentice","year":"1966","unstructured":"Prentice CRM, McNicol GP, Douglas AS. Effects on blood coagulation of normal and atheromatous aortic tissue. J Clin Path. 1966;19:154\u20138.","journal-title":"J Clin Path"},{"key":"3028_CR11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12185-009-0410-6","volume":"90","author":"T Hayashi","year":"2009","unstructured":"Hayashi T, Morishita E, Ohtake H, Oda Y, Asakura H, Nakao S. Expression of annexin II in experimental abdominal aortic aneurysms. Int J Hematol. 2009;90:336\u201342.","journal-title":"Int J Hematol"},{"key":"3028_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.thromres.2008.03.027","volume":"123","author":"T Hayashi","year":"2008","unstructured":"Hayashi T, Morishita E, Ohtake H, Oda Y, Ohta K, Arahata M, et al. Expression on annexin II in human artherosclerotic abdominal aortic aneurysms. Thromb Res. 2008;123:274\u201380.","journal-title":"Thromb Res"},{"key":"3028_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-6632.1997.tb52013.x","volume":"811","author":"KA Hajjar","year":"1997","unstructured":"Hajjar KA, Menell JS. Annexin II: a novel mediator of cell surface plasmin generation. Ann NY Acad Sci. 1997;811:337\u201349.","journal-title":"Ann NY Acad Sci"},{"key":"3028_CR14","doi-asserted-by":"crossref","first-page":"21191","DOI":"10.1016\/S0021-9258(17)31947-6","volume":"269","author":"KA Hajjar","year":"1994","unstructured":"Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen\/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem. 1994;269:21191\u20137.","journal-title":"J Biol Chem"},{"key":"3028_CR15","doi-asserted-by":"crossref","first-page":"21198","DOI":"10.1016\/S0021-9258(17)31948-8","volume":"269","author":"GM Cesarman","year":"1994","unstructured":"Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen\/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem. 1994;269:21198\u2013203.","journal-title":"J Biol Chem"},{"key":"3028_CR16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","volume":"340","author":"JS Menell","year":"1999","unstructured":"Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J med. 1999;340:994\u20131004.","journal-title":"N Engl J med"},{"key":"3028_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.thromres.2006.01.017","volume":"119","author":"S Madoiwa","year":"2007","unstructured":"Madoiwa S, Someya T, Hironaka M, Kobayashi H, Ohmori T, Mimuro J, et al. Annexin 2 and hemorrhagic disorder in vascular intimal carcinomatosis. Thromb Res. 2007;119:229\u201340.","journal-title":"Thromb Res"},{"key":"3028_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6605128","volume":"101","author":"Y Ohno","year":"2009","unstructured":"Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer. 2009;101:287\u201394.","journal-title":"Br J Cancer"},{"key":"3028_CR19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcb.21835","volume":"105","author":"Y Shiozawa","year":"2008","unstructured":"Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, et al. Annexin II\/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem. 2008;105:370\u201380.","journal-title":"J Cell Biochem"},{"key":"3028_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12155","volume":"11","author":"H Wada","year":"2013","unstructured":"Wada H, Thachil J, Di Nisio M, Mathew P, Kuwosawa S, Gando S, et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemos. 2013;11:761\u20137.","journal-title":"J Thromb Haemos"},{"key":"3028_CR21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF02286787","volume":"10","author":"DM Aboulafia","year":"1996","unstructured":"Aboulafia DM, Aboulafia ED. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg. 1996;10:396\u2013405.","journal-title":"Ann Vasc Surg"},{"key":"3028_CR22","first-page":"829","volume":"48","author":"K Tanaka","year":"1987","unstructured":"Tanaka K, Ito K, Ohgi S, Tsujimoto M, Okada M, Hara H, et al. Abdominal aortic aneurysm complicated by disseminated intravascular coagulation(DIC). J Jpn Surg Assoc. 1987;48:829\u201332.","journal-title":"J Jpn Surg Assoc"},{"key":"3028_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3400\/avd.cr.15-00103","volume":"8","author":"S Kotani","year":"2015","unstructured":"Kotani S. A case of disseminated intravascular coagulation after thoracic endovascular aortic repair. Ann Vasc Dis. 2015;8:334\u20136.","journal-title":"Ann Vasc Dis"},{"key":"3028_CR24","first-page":"1820","volume":"30","author":"K Takahashi","year":"1989","unstructured":"Takahashi K, Ichikawa Y, Arimori S. Disseminated intravascular coagulation related to artheriosclerosis and aneurysm of aorta: successful management with self-subcutaneous injection of heparin sodium. Rinsho Ketsueki. 1989;30:1820\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"3028_CR25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.athoracsur.2008.10.033","volume":"88","author":"K Yamamoto","year":"2009","unstructured":"Yamamoto K, Ito H, Hiraiwa T, Tanaka K. Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection. Ann Thorac Surg. 2009;88:1331\u20133.","journal-title":"Ann Thorac Surg"},{"key":"3028_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-018-02567-w","volume":"109","author":"D Minakata","year":"2019","unstructured":"Minakata D, Fujiwara S, Ikeda T, Kawaguchi S, Toda Y, Ito S, et al. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. Int J Hematol. 2019;109:141\u20136.","journal-title":"Int J Hematol"},{"key":"3028_CR27","first-page":"30","volume":"42","author":"K Yoneda","year":"2001","unstructured":"Yoneda K, Amano I, Tanaka H, Yagi H, Tsukaguchi N, Morii T, et al. Effective use of camostat mesylate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm. Rinsho Ketsueki. 2001;42:30\u20134.","journal-title":"Rinsho Ketsueki"},{"key":"3028_CR28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MBC.0000000000000031","volume":"25","author":"K Hoshina","year":"2014","unstructured":"Hoshina K, Shigematsu K, Hosaka A, Okamoto H, Miyata T, Watanabe T. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in abdominal aortic aneurysm. Blood Coagul Fibrinolysis. 2014;25:389\u201391.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3028_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02992-w","author":"T Ikezoe","year":"2020","unstructured":"Ikezoe T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies. Int J Hematol. 2020. https:\/\/doi.org\/10.1007\/s12185-020-02992-w.","journal-title":"Int J Hematol"},{"key":"3028_CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12185-015-1899-5","volume":"103","author":"T Aota","year":"2016","unstructured":"Aota T, Wada H, Yamashita Y, Matsumoto T, Ohishi K, Suzuki K, et al. The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC. Int J Hematol. 2016;103:173\u20139.","journal-title":"Int J Hematol"},{"key":"3028_CR31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12185-017-2190-8","volume":"105","author":"H Yokoyama","year":"2017","unstructured":"Yokoyama H, Takahashi N, Katsuoka Y, Inomata M, Ito T, Meguro K, et al. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum. Int J Hematol. 2017;105:606\u201313.","journal-title":"Int J Hematol"},{"key":"3028_CR32","first-page":"73","volume":"22","author":"A Danhof","year":"1992","unstructured":"Danhof A, de Boer A, Magnani HN, Stiekema JC. Pharmacokinetic considerations on Orgaran (Org10172) therapy. Hemostasis. 1992;22:73\u201384.","journal-title":"Hemostasis"},{"key":"3028_CR33","first-page":"1700","volume":"50","author":"K Togami","year":"2009","unstructured":"Togami K, Nagai Y, Arima H, Shimoji S, Kimura T, Inoue D, et al. Successful treatment of chronic disseminated intravascular coagulation syndrome with continuous subcutaneous infusion of heparin using a mobile infusion pump: report of 2 cases. Rinsho Ketsueki. 2009;50:1700\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"3028_CR34","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/BF00311684","volume":"25","author":"J Oba","year":"1995","unstructured":"Oba J, Shiiya N, Matsui Y, Goda T, Sakuma M, Yasuda K. Preoperative disseminated intravascular coagulation (DIC) associated with aortic aneurysm\u2014dose it need to be corrected before surgery? Surg Today. 1995;25:1011\u20134.","journal-title":"Surg Today"},{"key":"3028_CR35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-2141.2001.02817.x","volume":"113","author":"D Cummins","year":"2001","unstructured":"Cummins D, Segal H, Hunt BJ, Awad R, Maddox A. Chronic disseminated intravascular coagulation after surgery for abdominal aortic aneurysm: clinical and haemostatic response to dalteparin. Br J Haematol. 2001;113:658\u201360.","journal-title":"Br J Haematol"},{"key":"3028_CR36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1253\/circj.69.1150","volume":"69","author":"Y Ontachi","year":"2005","unstructured":"Ontachi Y, Asakura H, Arahata M, Kadohira Y, Maekawa M, Hayashi T, et al. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. Circ J. 2005;69:1150\u20133.","journal-title":"Circ J"},{"key":"3028_CR37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","volume":"661","author":"S Fujii","year":"1981","unstructured":"Fujii S, Hitomi Y. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta. 1981;661:342\u20135.","journal-title":"Biochim Biophys Acta"},{"key":"3028_CR38","first-page":"767","volume":"27","author":"S Tsukagoshi","year":"2000","unstructured":"Tsukagoshi S. Pharmacokinetics studies of nafamostat mesylate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation. Gan To Kagaku Ryoho. 2000;27:767\u201374.","journal-title":"Gan To Kagaku Ryoho"},{"key":"3028_CR39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/0306-3623(95)00072-0","volume":"26","author":"S Muto","year":"1995","unstructured":"Muto S, Imai M, Asano Y. Mechanisms of hyperkalemia caused by nafamostat mesylate. Gen Pharmacol. 1995;26:1627\u201332.","journal-title":"Gen Pharmacol"},{"key":"3028_CR40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jth.14858","volume":"18","author":"H Asakura","year":"2020","unstructured":"Asakura H, Ogawa H. Potential of heparin and nafamostat combination therapy for COVID-19. J Thromb Haemost. 2020;18:1521\u20132.","journal-title":"J Thromb Haemost"},{"key":"3028_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"5","author":"H Saito","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007;5:31\u201341.","journal-title":"J Thromb Haemost"},{"key":"3028_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7133\/jca.16-00001","volume":"56","author":"K Kazuno","year":"2016","unstructured":"Kazuno K, Murata S, Sato H, Urata M. Efficacy of recombinant human soluble thrombomodulin in an outpatient with chronic disseminated intravascular coagulation complicating thoracic aortic aneurysm after TEVAR. J Jpn Coll Angiol. 2016;56:35\u20138.","journal-title":"J Jpn Coll Angiol"},{"key":"3028_CR43","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3919\/jjsa.78.1506","volume":"78","author":"T Ito","year":"2017","unstructured":"Ito T, Watanabe T, Uchiyama H, Yasuda N, Kawaharada N. Preoperative recombinant thrombomodulin treatment for disseminated intravascular coagulation in patients with aortic pathology. J Jpn Surg Assoc. 2017;78:1506\u201310.","journal-title":"J Jpn Surg Assoc"},{"key":"3028_CR44","first-page":"2300","volume":"55","author":"K Hayakawa","year":"2014","unstructured":"Hayakawa K, Tamura S, Gima H, Hayakawa T, Kurihara T, Ooura M, et al. Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm. Rinsho Ketsueki. 2014;55:2300\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"3028_CR45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/L14-5014-3","volume":"161","author":"T Hayashi","year":"2014","unstructured":"Hayashi T, Nakagawa N, Kadohira Y, Morishita E, Asakura H. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med. 2014;161:158\u20139.","journal-title":"Ann Intern Med"},{"key":"3028_CR46","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2169\/internalmedicine.8666-16","volume":"56","author":"Y Kadohira","year":"2017","unstructured":"Kadohira Y, Yamada S, Matsuura E, Hayashi T, Morishita E, Nakao S, et al. Aortic aneurysm-associated disseminated intravascular coagulation that responded well to a switch from warfarin to rivaroxaban. Intern Med. 2017;56:2913\u20137.","journal-title":"Intern Med"},{"key":"3028_CR47","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2169\/internalmedicine.54.4942","volume":"54","author":"H Kawano","year":"2015","unstructured":"Kawano H, Hata T, Uda A, Maemura K. Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm. Intern Med. 2015;54:2625\u20138.","journal-title":"Intern Med"},{"key":"3028_CR48","first-page":"247","volume":"27","author":"T Ito","year":"2018","unstructured":"Ito T, Mikami T, Numaguchi R, Watanabe T, Nakazawa J, Kawaharada N. A case of disseminated intravascular coagulation caused by dissecting aortic aneurysm in which coagulation factor XIII was effective for hemostasis. Jpn J Vasc Surg. 2018;27:247\u201350.","journal-title":"Jpn J Vasc Surg"},{"key":"3028_CR49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000046542","volume":"105","author":"G Munter","year":"2001","unstructured":"Munter G, Hershko C. Increased warfarin sensitivity as an early manifestation of occult prostate cancer with chronic disseminated intravascular coagulation. Acta Haematol. 2001;105:97\u20139.","journal-title":"Acta Haematol"},{"key":"3028_CR50","first-page":"48","volume":"26","author":"K Otsui","year":"2014","unstructured":"Otsui K, Yamamoto M, Aoki H, Ozawa T, Domoto K, Suzuki A, et al. A super-elderly case of abdominal aortic aneurysm associated with chronic disseminated intravascular coagulation. J Cardiol Cases. 2014;26:48\u201351.","journal-title":"J Cardiol Cases"},{"key":"3028_CR51","first-page":"e5486","volume":"11","author":"A Werbin","year":"2019","unstructured":"Werbin A, Fong A, Shahin G, Henderson A, Surry L. Tranexamic acid use in a patient with a life threatening bleed exacerbated by coagulopathy due to an aortic aneurysm with an endoleak: a case report. Cureus. 2019;11:e5486.","journal-title":"Cureus"},{"key":"3028_CR52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood.V19.6.694.694","volume":"19","author":"RL Naeye","year":"1962","unstructured":"Naeye RL. Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood. 1962;19:694\u2013701.","journal-title":"Blood"},{"key":"3028_CR53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJM196905152802006","volume":"280","author":"C Charytan","year":"1969","unstructured":"Charytan C, Purtilo D. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med. 1969;280:1102\u20134.","journal-title":"N Engl J Med"},{"key":"3028_CR54","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1152\/physrev.00023.2020","volume":"100","author":"H Ogawa","year":"2020","unstructured":"Ogawa H, Asakura H. Consideration of tranexamic acid administration to COVID-19 patients. Physiol Rev. 2020;100:1595\u20136.","journal-title":"Physiol Rev"},{"key":"3028_CR55","first-page":"1459","volume":"56","author":"M Taniguchi","year":"1995","unstructured":"Taniguchi M, Ueda Y, Toyoda K, Maeda M. An operated case of retroperitoneal cavernous hemangioma complicated by Kasabach-Merritt syndrome. J Jpn Surg Assoc. 1995;56:1459\u201363.","journal-title":"J Jpn Surg Assoc"},{"key":"3028_CR56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1752-1947-4-92","volume":"4","author":"UH Beier","year":"2010","unstructured":"Beier UH, Schmidt ML, Hast H, Kecskes S, Valentino LA. Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report. J Med Case Rep. 2010;4:92.","journal-title":"J Med Case Rep"},{"key":"3028_CR57","first-page":"202","volume":"29","author":"Y Hashimoto","year":"1989","unstructured":"Hashimoto Y, Eto K, Uchino M, Araki S. Blue-rubber-bleb-nevus syndrome presented vascular dementia and chronic DIC\u2014a case report. Rinsho Shinkeigaku. 1989;29:202\u20138.","journal-title":"Rinsho Shinkeigaku"},{"key":"3028_CR58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1447-0756.1999.tb01159.x","volume":"25","author":"O Wada","year":"1999","unstructured":"Wada O, Unno N, Matsuoka R, Taketani Y. A case report: pregnancy complicated by blue rubber-bleb nevus syndrome. J Obstet Gynecol Res. 1999;25:261\u20133.","journal-title":"J Obstet Gynecol Res"},{"key":"3028_CR59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11604-019-00885-5","volume":"38","author":"H Mimura","year":"2020","unstructured":"Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, et al. Japanese clinical practice guidelines for vascular anomalies 2017. Jpn J Radiol. 2020;38:287\u2013342.","journal-title":"Jpn J Radiol"},{"key":"3028_CR60","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpedi.1940.01990160135009","volume":"59","author":"HH Kasabach","year":"1940","unstructured":"Kasabach HH, Merritt KK. Caplillary hemangioma with extensive purpura: report of a case. Am J Dis Child. 1940;59:1063\u201370.","journal-title":"Am J Dis Child"},{"key":"3028_CR61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/neurintsurg-2015-012255","volume":"9","author":"JJ Heit","year":"2017","unstructured":"Heit JJ, Do HM, Prestigiacomo CJ, Delgado-Almandoz JA, English J, Gandhi CD, et al. Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations. J Neurointerv Surg. 2017;9:611\u20137.","journal-title":"J Neurointerv Surg"},{"key":"3028_CR62","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.bjps.2013.07.033","volume":"66","author":"F Steiner","year":"2013","unstructured":"Steiner F, FitzJohn T, Tan ST. Surgical treatment for venous malformation. J Plast Reconstr Aesthet Surg. 2013;66:1741\u20139.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"3028_CR63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SAP.0b013e318276daa6","volume":"73","author":"LW Ma","year":"2014","unstructured":"Ma LW, Levi B, Oppenheimer AJ, Kasten SJ. Intralesional laser therapy for vascular malformations. Ann Plast Surg. 2014;73:547\u201351.","journal-title":"Ann Plast Surg"},{"key":"3028_CR64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0268355516684694","volume":"33","author":"GB Langbroek","year":"2018","unstructured":"Langbroek GB, Horbach SE, van der Vleuten CJ, Ubbink DT, van der Horst CM. Compression therapy for congenital low-flow vascular malformations of the extremities: a systematic review. Phlebology. 2018;33:5\u201313.","journal-title":"Phlebology"},{"key":"3028_CR65","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","volume":"144","author":"A Dompmartin","year":"2008","unstructured":"Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144:873\u20137.","journal-title":"Arch Dermatol"},{"key":"3028_CR66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/MBC.0000000000000666","volume":"28","author":"A Yasumoto","year":"2017","unstructured":"Yasumoto A, Ishiura R, Narushima M, Yatomi Y. Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations. Blood Coagul Fibrinolysis. 2017;28:670\u20134.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3028_CR67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11239-013-1024-7","volume":"38","author":"C Vandenbriele","year":"2014","unstructured":"Vandenbriele C, Vanassche T, Peetermans M, Verhamme P, Peerlinck K. Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation. J Thromb Thrombolysis. 2014;38:121\u20133.","journal-title":"J Thromb Thrombolysis"},{"key":"3028_CR68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/lrb.2017.0029","volume":"16","author":"JM Mack","year":"2018","unstructured":"Mack JM, Richter GT, Crary SE. Effectiveness and safety of treatment with direct oral anticoagulant rivaroxaban in patients with slow-flow vascular malformations: a case series. Lymphat Res Biol. 2018;16:278\u201381.","journal-title":"Lymphat Res Biol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-020-03028-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-03028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T10:47:12Z","timestamp":1611226032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-020-03028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-03028-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}